Timely Antiviral Administration During an Influenza Pandemic: Key Components
Identifieur interne : 000647 ( Pmc/Corpus ); précédent : 000646; suivant : 000648Timely Antiviral Administration During an Influenza Pandemic: Key Components
Auteurs : Lisa M. Koonin ; Anita PatelSource :
- American Journal of Public Health [ 0090-0036 ] ; 2018.
Abstract
Prompt treatment of ill persons with influenza antivirals will be an important part of a future pandemic influenza response.
This essay reviews key lessons learned from the 2009 H1N1 pandemic and the changing landscape of antiviral drug availability, and identifies and describes the multiple components needed to ensure the timely administration of antiviral drugs during a future pandemic.
Fortunately, many of these planning efforts can take place before a pandemic strikes to improve outcomes during a future public health emergency.
Url:
DOI: 10.2105/AJPH.2018.304609
PubMed: 30192657
PubMed Central: 6129661
Links to Exploration step
PMC:6129661Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Timely Antiviral Administration During an Influenza Pandemic: Key Components</title><author><name sortKey="Koonin, Lisa M" sort="Koonin, Lisa M" uniqKey="Koonin L" first="Lisa M." last="Koonin">Lisa M. Koonin</name></author><author><name sortKey="Patel, Anita" sort="Patel, Anita" uniqKey="Patel A" first="Anita" last="Patel">Anita Patel</name></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">30192657</idno><idno type="pmc">6129661</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6129661</idno><idno type="RBID">PMC:6129661</idno><idno type="doi">10.2105/AJPH.2018.304609</idno><date when="2018">2018</date><idno type="wicri:Area/Pmc/Corpus">000647</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000647</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Timely Antiviral Administration During an Influenza Pandemic: Key Components</title><author><name sortKey="Koonin, Lisa M" sort="Koonin, Lisa M" uniqKey="Koonin L" first="Lisa M." last="Koonin">Lisa M. Koonin</name></author><author><name sortKey="Patel, Anita" sort="Patel, Anita" uniqKey="Patel A" first="Anita" last="Patel">Anita Patel</name></author></analytic><series><title level="j">American Journal of Public Health</title><idno type="ISSN">0090-0036</idno><idno type="eISSN">1541-0048</idno><imprint><date when="2018">2018</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p>Prompt treatment of ill persons with influenza antivirals will be an important part of a future pandemic influenza response.</p><p>This essay reviews key lessons learned from the 2009 H1N1 pandemic and the changing landscape of antiviral drug availability, and identifies and describes the multiple components needed to ensure the timely administration of antiviral drugs during a future pandemic.</p><p>Fortunately, many of these planning efforts can take place before a pandemic strikes to improve outcomes during a future public health emergency.</p></div></front></TEI><pmc article-type="research-article"><pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<front><journal-meta><journal-id journal-id-type="nlm-ta">Am J Public Health</journal-id><journal-id journal-id-type="iso-abbrev">Am J Public Health</journal-id><journal-id journal-id-type="publisher-id">ajph</journal-id><journal-title-group><journal-title>American Journal of Public Health</journal-title></journal-title-group><issn pub-type="ppub">0090-0036</issn><issn pub-type="epub">1541-0048</issn><publisher><publisher-name>American Public Health Association</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">30192657</article-id><article-id pub-id-type="pmc">6129661</article-id><article-id pub-id-type="publisher-id">201822758</article-id><article-id pub-id-type="doi">10.2105/AJPH.2018.304609</article-id><article-categories><subj-group subj-group-type="hwp-journal-coll"><subject>Health Care Facilities/Services</subject><subject>Health Policy</subject><subject>Access to Care</subject><subject>Influenza</subject><subject>Public Health Practice</subject></subj-group><subj-group subj-group-type="heading"><subject>AJPH Methods</subject><subj-group><subject>Influenza</subject></subj-group></subj-group></article-categories><title-group><article-title>Timely Antiviral Administration During an Influenza Pandemic: Key Components</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Koonin</surname><given-names>Lisa M.</given-names></name><degrees>DrPH, MN, MPH</degrees></contrib><contrib contrib-type="author"><name><surname>Patel</surname><given-names>Anita</given-names></name><degrees>PharmD, MS</degrees></contrib><aff>Both authors are with the Influenza Coordination Unit, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA.</aff></contrib-group><author-notes><corresp>Correspondence should be sent to Lisa M. Koonin, DrPH, MN, MPH, Centers for Disease Control and Prevention, 1600 Clifton Rd, NE, Mailstop A-27, Atlanta, GA 30329 (e-mail: <email>LKoonin@cdc.gov</email>). Reprints can be ordered at <ext-link ext-link-type="uri" xlink:href="http://www.ajph.org">http://www.ajph.org</ext-link> by clicking the “Reprints” link.</corresp><fn><p><bold>CONTRIBUTORS</bold></p><p>L. M. Koonin originated the concept, and both authors developed and edited the essay.</p></fn><fn><p>Peer Reviewed</p></fn></author-notes><pub-date pub-type="ppub"><month>9</month><year>2018</year></pub-date><pub-date pub-type="epub"><month>9</month><year>2018</year></pub-date><pub-date pub-type="pmc-release"><month>9</month><year>2018</year></pub-date><pmc-comment> PMC Release delay is 0 months and 0 days and was based on the
<volume>108</volume><issue>Suppl 3</issue><fpage>S215</fpage><lpage>S220</lpage><history><date date-type="accepted"><day>13</day><month>6</month><year>2018</year></date></history><permissions><copyright-statement>© American Public Health Association 2018</copyright-statement><copyright-year>2018</copyright-year></permissions><self-uri content-type="pdf" xlink:type="simple" xlink:href="AJPH.2018.304609.pdf"></self-uri><abstract><p>Prompt treatment of ill persons with influenza antivirals will be an important part of a future pandemic influenza response.</p><p>This essay reviews key lessons learned from the 2009 H1N1 pandemic and the changing landscape of antiviral drug availability, and identifies and describes the multiple components needed to ensure the timely administration of antiviral drugs during a future pandemic.</p><p>Fortunately, many of these planning efforts can take place before a pandemic strikes to improve outcomes during a future public health emergency.</p></abstract><counts><page-count count="6"></page-count></counts></article-meta></front></pmc></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000647 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 000647 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= PandemieGrippaleV1
|flux= Pmc
|étape= Corpus
|type= RBID
|clé= PMC:6129661
|texte= Timely Antiviral Administration During an Influenza Pandemic: Key Components
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/RBID.i -Sk "pubmed:30192657" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a PandemieGrippaleV1
| This area was generated with Dilib version V0.6.34. |  |